Improved monitoring of 2-Hydroxyglutarate to stage response of combined Vorasidenib and Tumor Specific Peptide Vaccine therapies in recurrent IDH1 mutant lower grade glioma
Research Grant
Administered By
Radiology
Awarded By
National Cancer Institute
Start Date
September 21, 2022
End Date
August 31, 2026
Administered By
Radiology
Awarded By
National Cancer Institute
Start Date
September 21, 2022
End Date
August 31, 2026